Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (2) , 887-895
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosisFrontiers in Bioscience-Landmark, 2008
- Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitorsFrontiers in Bioscience-Landmark, 2008
- Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivoInternational Journal of Cancer, 2007
- Crystal Structure of Aminopeptidase N (Proteobacteria Alanyl Aminopeptidase) from Escherichia coli and Conformational Change of Methionine 260 Involved in Substrate RecognitionJournal of Biological Chemistry, 2006
- Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's diseaseJournal of Autoimmunity, 2006
- Progress in the Development of Aminopeptidase N (APN/CD13) InhibitorsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- CD13/aminopeptidase N–induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritisArthritis & Rheumatism, 2002
- Protease Inhibitors: Current Status and Future ProspectsJournal of Medicinal Chemistry, 2000
- Novel Small Molecule Nonpeptide Aminopeptidase N Inhibitors with a Cyclic Imide SkeletonJournal of Enzyme Inhibition, 1999
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997